Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.93% is 19% below its 5-year average of 2.38%, around the middle of its 5-year range (0.68%–3.43%).
54.40% above its 12-month average of 1.25%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-12-31.
RETURN ON ASSETS (ROA)
1.93%
RETURN ON ASSETS (ROA) AVG TTM
1.25%
RETURN ON ASSETS (ROA) AVG 3Y
1.93%
RETURN ON ASSETS (ROA) AVG 5Y
2.38%
RETURN ON ASSETS (ROA) AVG 10Y
3.20%
RETURN ON ASSETS (ROA) AVG 15Y
4.04%
RETURN ON ASSETS (ROA) AVG 20Y
4.54%
CURRENT VS TTM AVG
+54.40%
CURRENT VS 3Y AVG
-0.13%
CURRENT VS 5Y AVG
-18.85%
CURRENT VS 10Y AVG
-39.70%
CURRENT VS 15Y AVG
-52.20%
CURRENT VS 20Y AVG
-57.49%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-62.45%
vs the sector median at left
CVS Health Corp.
Market Cap
$122.13B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$124.07B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$118.24B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$131.96B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$132.36B
Return on Assets (ROA)
16.06%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$105.00B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$104.77B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$144.17B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVS Health Corp. (CVS) | $122.13B | 1.93% | 1.25% | 1.93% | 2.38% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.07B | 15.04% | 13.09% | 12.00% | 11.68% |
| Medtronic plc (MDT)vs › | $118.24B | 5.61% | 5.13% | 4.62% | 4.65% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.96B | 10.59% | -0.92% | 3.28% | 1.99% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 16.06% | 6.37% | 11.74% | 14.58% |
| Stryker Corporation (SYK)vs › | $105.00B | 7.78% | 6.88% | 7.02% | 6.41% |
| McKesson Corporation (MCK)vs › | $104.77B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $103.24B | 3.12% | 5.18% | 5.31% | 6.19% |
| Danaher Corporation (DHR)vs › | $144.17B | 4.33% | 4.68% | 5.89% | 6.01% |
| GSK plc (GSK)vs › | $97.83B | 7.91% | 6.85% | 11.28% | 9.07% |
ROA
1.9%
ROE
6.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 0.68% |
| 2024-12-31 | 1.82% |
| 2023-12-31 | 3.34% |
| 2022-12-31 | 1.89% |
| 2021-12-31 | 3.43% |
| 2020-12-31 | 3.11% |
| 2019-12-31 | 2.98% |
| 2018-12-31 | -0.30% |
| 2017-12-31 | 6.96% |
| 2016-12-31 | 5.63% |
| 2015-12-31 | 5.67% |
| 2014-12-31 | 6.26% |
| 2013-12-31 | 6.42% |
| 2012-12-31 | 5.84% |
| 2011-12-31 | 5.36% |
| 2010-12-31 | 5.51% |
| 2009-12-31 | 6.00% |
| 2008-12-31 | 5.27% |
| 2007-12-31 | 4.82% |
| 2006-12-31 | 6.65% |
| 2005-12-31 | 8.01% |
| 2004-12-31 | 6.32% |
| 2003-12-31 | 8.04% |
| 2002-12-31 | 7.43% |
| 2001-12-31 | 4.78% |
| 2000-12-31 | 9.38% |
| 1999-12-31 | 8.73% |
| 1998-12-31 | 5.75% |
| 1997-12-31 | 1.49% |
| 1996-12-31 | 3.66% |
